IMRA Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 37.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $619,058.41

IMARA Insider Trading History Chart

This chart shows the insider buying and selling history at IMARA by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$619ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

IMARA Share Price & Price History

Current Price: $47.05
Price Change: Price Decrease of -0.7617 (-1.59%)
As of 05/29/2025 01:00 AM ET

This chart shows the closing price history over time for IMRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for IMARA (NASDAQ:IMRA)

49.28% of IMARA stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at IMRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M$0$200MTotal InflowsTotal Outflows
IMARA logo
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Read More on IMARA

Today's Range

Now: $47.05
Low: $46.85
High: $48.25

50 Day Range

MA: $17.12
Low: $6.32
High: $25.28

52 Week Range

Now: $47.05
Low: $0.97
High: $6.32

Volume

21,639 shs

Average Volume

138,364 shs

Market Capitalization

$1.23 billion

P/E Ratio

941.28

Dividend Yield

N/A

Beta

1.09

Who are the company insiders with the largest holdings of IMARA?

IMARA's top insider shareholders include:
  1. Joseph P Lyssikatos (Insider)
  2. Anish Patel (COO)
  3. Benjamin Hohl (CFO)
Learn More about top insider investors at IMARA.